Skip to main content
BROOKS LABORATORIES LIMITED logo

BROOKS LABORATORIES LIMITED — Investor Relations & Filings

Ticker · BROOKS ISIN · INE650L01011 LEI · 984500FY0879C7971B73 BSE.NS Manufacturing
Filings indexed 498 across all filing types
Latest filing 2019-08-17 Regulatory Filings
Country IN India
Listing BSE.NS BROOKS

About BROOKS LABORATORIES LIMITED

https://www.brookslabs.net/

Brooks Laboratories Limited is a pharmaceutical manufacturing enterprise specializing in Contract Research and Manufacturing Services (CRAMS). The company focuses on the production of a diverse range of pharmaceutical formulations, including beta-lactam and non-beta-lactam products. Its portfolio encompasses various dosage forms such as dry powder injections, liquid injections, tablets, and capsules. Key therapeutic segments served include antibiotics, cardiovascular, gastrointestinal, and pain management. The company operates advanced manufacturing facilities designed to meet international quality standards, providing integrated solutions from formulation development to commercial-scale production. Brooks Laboratories emphasizes quality control and regulatory compliance to support its domestic and international client base.

Recent filings

Filing Released Lang Actions
Resignation
Regulatory Filings
2019-08-17 English
Updates
Regulatory Filings
2019-08-16 English
Financial Result Updates
Regulatory Filings
2019-08-14 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing about a scheduled Board of Directors meeting to consider and approve unaudited financial results for the first quarter ended June 30, 2019. It also mentions the closure of the trading window for insiders. The document is short (1771 characters) and serves as an intimation or announcement rather than containing the actual financial results or detailed report. It is an announcement under SEBI regulations about the board meeting and trading window closure, not the interim report itself. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement.
2019-08-05 English
Conversion
Regulatory Filings
2019-07-26 English
Updates
Regulatory Filings
2019-07-22 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.